Exploring Longevity Medicine with Daniel Tawfik In the 96th episode of the Wise Athletes Podcast, hosted by Joe Lavelle and Dr. Glenn Winkle, the show dives into the world of longevity medicine with Daniel Tewfik. Tewfik is the co-founder of Healthspan, a telemedicine provider, also known as distance healthcare. The company specializes in treatments aimed…

The Next Alzheimer's Disease Trial Needs Rapamycin This thought-provoking study advocates for human rapamycin trials in Alzheimer's disease. Why this drug? Rapa is already known for its anti-aging properties, as demonstrated in multiple experiments. Alzheimer's is an age-related illness. The theory is that targeting the aging processes may help slow or even prevent AD and…

Long-Term Rapamycin Exposure Tests Closer to Home In this rapamycin (Rapa) study, the experiments lasted for 14 months. It's a significant step forward compared to other research carried out on lab mice. But why monkeys? Primates are closer relatives to humans than rodents, making the results more relevant to us. Also, the small size of…

Heart Benefits from Transient Rapamycin Treatment Imagine a simple drug that could improve your heart's function even after you stop taking it. It sounds like science fiction, but it's not. Rapamycin, or Rapa, is an existing natural drug that has great promise for the future of heart health. This article explores a 2017 study by…

Introduction: Dirt Drug Boosts Lifespan 60% in Mice The FDA approved rapamycin, a special compound found in soil, over 20 years ago. The drug's full potential is still unknown, hence the continual research. In this study, middle-aged mice were treated with Rapa for only 3 months (90 days). The treatment groups were 600 days old,…